Abstract
Lay Summary This retrospective study assessed the use of Janus kinase inhibitors in treating chronic pouchitis. While showing relative safety, Janus kinase inhibitors demonstrated effectiveness in <50% of cases, cautioning against their use as first-line agents. Larger randomized trials are recommended for further investigation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have